You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 254 No. 22, December 13, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine

D. J. Weber, W. A. Rutala, G. P. Samsa, J. E. Santimaw and S. M. Lemon

Factors associated with lack of antibody response to the hepatitis B virus plasma vaccine were retrospectively evaluated by means of a logistic regression in 194 previously seronegative staff members of a community hospital. All subjects had received three doses of vaccine by intramuscular buttock injection using a 1-in, 23-gauge needle. Overall, only 55.7% of subjects developed detectable antibody to hepatitis B surface antigen in serum after immunization. The weight-height index served as a surrogate measure of obesity. Predictors of poor immunogenic response to hepatitis B vaccine included higher weight-height index, older age, and vaccine batch. Sex, race, timing of vaccine doses, and timing of postimmunization determination of antibody to hepatitis B surface antigen were not predictors of vaccine efficacy.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Immunogenicity in humans of an edible vaccine for hepatitis B
Thanavala et al.
Proc. Natl. Acad. Sci. USA 2005;102:3378-3382.
ABSTRACT | FULL TEXT  

Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial
Halperin et al.
CMAJ 2003;169:111-117.
ABSTRACT | FULL TEXT  

A Randomized Trial of Alternative Two- and Three-Dose Hepatitis B Vaccination Regimens in Adolescents: Antibody Responses, Safety, and Immunologic Memory
Cassidy et al.
Pediatrics 2001;107:626-631.
ABSTRACT | FULL TEXT  

Hepatitis B Vaccination in Pregnancy: Factors Influencing Efficacy
INGARDIA et al.
Obstet Gynecol 1999;93:983-986.
ABSTRACT | FULL TEXT  

Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host
Pirofski and Casadevall
Clin. Microbiol. Rev. 1998;11:1-26.
ABSTRACT | FULL TEXT  

Vaccines to Prevent Viral Hepatitis
Lemon and Thomas
NEJM 1997;336:196-204.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.